Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paired box protein Pax-9 (PAX9) is a transcription factor from the paired box gene family that plays a critical role in mammalian development, particularly in the formation of teeth and craniofacial structures[1][2][3][4][5]. PAX9 binds to DNA using its paired domain and regulates the expression of genes necessary for odontogenesis, ribosome biogenesis, and other developmental pathways[1][2]. In humans, mutations in PAX9 are a common cause of familial tooth agenesis (oligodontia), usually affecting the posterior teeth without other systemic abnormalities[2][3][4][5]. PAX9 has also been implicated in the pathogenesis of certain cancers such as lung cancer, where gene amplification may contribute to oncogenesis[3]. There are currently no drugs known that target PAX9 directly, and it is not commonly considered a therapeutic pharmacological target, but it is an important biomarker and gene of interest for developmental biology and genetic disease studies[2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paired box protein Pax-9 (PAX9).